Skip to main content
Home
About Us
Contact Us
Donations & Foundations
Patient Stories
Events
News
Executive Board
New Diagnosis
Patients
Online Scheduling
Billing and Financial Support
Donations and Foundations
Teams
Clinical Researchers
Dietitians
Doctors
Financial Advocates
Genetic Counselors
Lab Scientists
Leadership
Nurse Navigators
Nurse Practitioners
Patient Care Coordinators
Pharmacists
Physician Assistants
Social Workers
Services
Locations
Professionals
Clinical Trials
Employers
Genetic Counseling
PowerShare Records
Schedule Consult
Survivorship
ME: (207)303-3300
NH: (603)828-0100
Scheduling
Payments
CareSpace Portal
Careers
Home
About Us
Contact Us
Donations & Foundations
Patient Stories
Events
News
Executive Board
Rock Row Move
New Diagnosis
Patients
Online Scheduling
Billing and Financial Support
Donations and Foundations
Teams
Clinical Researchers
Dietitians
Doctors
Financial Advocates
Genetic Counselors
Lab Scientists
Leadership
Nurse Navigators
Nurse Practitioners
Patient Care Coordinators
Pharmacists
Physician Assistants
Social Workers
Services
Locations
Professionals
Clinical Trials
Employers
Genetic Counseling
PowerShare Records
Schedule Consult
Survivorship
Leukemia: 21-279
Trial ID
Trial Sponsor
A Phase 2 Trial of Zanubrutinib and Venetoclax in Previously Treated CLL/SLL Patients
Online Scheduling
Call Scheduling: 207-303-3230
Related Services
Leukemia
